ArticleOncoTargets and therapy2015

Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer.

Liya Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.